The detailed heatmap allows for the identification of specific genes within these sets that show significant positive or negative correlations with SLC22A3, providing insights into potential mechanisms through which SLC22A3 may influence CRC progression and patient outcomes. The gene discussed is SLC22A3; the disease is colorectal carcinoma.